Quarterly report pursuant to sections 13 or 15(d)

Preferred Stock (Tables)

v2.4.0.6
Preferred Stock (Tables)
3 Months Ended
Mar. 31, 2013
Pro Forma Effect of Series E Preferred Stock

Tables follow that give pro forma effect of the Series E correction as if the correction had occurred on February 21, 2013:

 

     March 31, 2013  
     Balance Sheet
Line Items
    Series E
Adjustments
    Pro Forma  

Assets

   $ 38,029,406      $ 0      $ 38,029,406   
  

 

 

   

 

 

   

 

 

 

Liabilities

   $ 12,952,499      $ (4,804,850   $ 8,147,649   

Series E convertible redeemable preferred stock

     5,529,792        0        5,529,792   

Stockholders’ Equity

     19,547,115        4,804,850        24,351,965   
  

 

 

   

 

 

   

 

 

 

Total Liabilities, Series E & Stockholders’ Equity

   $ 38,029,406      $ 0      $ 38,029,406   
  

 

 

   

 

 

   

 

 

 
     March 31, 2013  
     Statement of
Operations
Line Items
    Series E
Adjustments
    Pro Forma  

Revenue

   $ 6,311,401      $ 0      $ 6,311,401   

Gross profit

     2,661,213        0        2,661,213   
  

 

 

   

 

 

   

 

 

 

Operating loss

     (2,891,781     0        (2,891,781

Non-operating expense

     (2,426,302     3,169,083        742,781   
  

 

 

   

 

 

   

 

 

 

Loss from continuing operations

     (5,318,083     3,169,083        (2,149,000

Net loss

     (5,318,083     3,169,083        (2,149,000

Preferred stock dividends and accretion

     (2,447,733     1,635,767        (811,966
  

 

 

   

 

 

   

 

 

 

Net loss attributable to common stockholders

   $ (7,765,816   $ 4,804,850      $ (2,960,966
  

 

 

   

 

 

   

 

 

 

Basic and diluted loss per common share:

      

Loss from continuing operations attributable to common stockholders

     (0.11       (0.04

Net loss attributable to common stockholders

     (0.11       (0.04

Basic and diluted weighted average shares outstanding

     71,658,506          71,658,506